Cumberland Pharmaceuticals (CPIX) Reports Q4 EPS of $0.03

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of $0.03, versus $0.10 reported last year. Revenue for the quarter came in at $8.04 million, versus $9.33 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
• Dycom Industries (DY) Tops Q2 EPS by 59c, Beats on Revenue
• Elastic NV. (ESTC) PT Raised to $80 at DA Davidson Ahead of Q1 Earnings